EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR)

Kseniya Halavina, Matthias Koschutnik, Carolina Donà, Maximilian Autherith, Fabian Petric, Anna Röckel, Georg Spinka, Daryush Danesh, Jürgen Puchinger, Martin Wiesholzer, Katharina Mascherbauer, Gregor Heitzinger und 10 weitere

JACC: Cardiovascular Interventions · 2024

DOI: 10.1016/j.jcin.2024.06.022 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Kseniya Halavina und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 2, Division of Cardiology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Quality of Life, Severity of Illness Index. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Universität Wien, Austrian Society of Cardiology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fluid overload (FO) subjects patients with severe aortic stenosis (AS) to increased risk for heart failure and death after valve replacement and can be objectively quantified using bioimpedance spectroscopy (BIS). OBJECTIVES: The authors hypothesized that in AS patients with concomitant FO, BIS-guided decongestion could improve prognosis and quality of life following transcatheter aortic valve replacement (TAVR). METHODS: This randomized, controlled trial enrolled 232 patients with severe AS scheduled for TAVR. FO was defined using a portable whole-body BIS device according to previously established cutoffs (≥1.0 L and/or ≥7%). Patients with FO (n = 111) were randomly assigned 1:1 to receive BIS-guided decongestion (n = 55) or decongestion by clinical judgment alone (n = 56) following TAVR. Patients without FO (n = 121) served as a control cohort. The primary endpoint was the composite of hospitalization for heart failure and/or all-cause death at 12 months. The secondary endpoint was the change from baseline to 12 months in the Kansas City Cardiomyopathy Questionnaire. RESULTS: The occurrence of the primary endpoint at 12 months was significantly lower in the BIS-guided vs the non-BIS-guided decongestion group (7/55 [12.7%, all deaths] vs 18/56 [32.1%, 9 hospitalizations for heart failure and 9 deaths]; HR: 0.36; 95% CI: 0.15-0.87; absolute risk reduction = -19.4%). Outcomes in the BIS-guided decongestion group were identical to the euvolemic control group (log-rank test, P = 0.7). BIS-guided decongestion was also associated with a higher increase in the Kansas City Cardiomyopathy Questionnaire score from baseline compared to non-BIS-guided decongestion (P = 0.001). CONCLUSIONS: In patients with severe AS and concomitant FO, quantitatively guided decongestive treatment and associated intensified management post-TAVR was associated with improved outcomes and quality of life compared to decongestion by clinical judgment alone. (Management of Fluid Overload in Patients Scheduled for Transcatheter Aortic Valve Replacement [EASE-TAVR]; NCT04556123).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementQuality of LifeSeverity of Illness IndexHeart FailureHumansFemaleMaleTreatment OutcomeAgedAged, 80 and overRisk FactorsTime FactorsDielectric SpectroscopyWater-Electrolyte ImbalanceAortic ValvePredictive Value of TestsRecovery of FunctionProspective Studies

Stichwörter der Autor:innen

TAVRcardiac decompensationcongestionoutcomevolume status

Autor:innen und Institutionen

  • Department of Internal Medicine 2, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Department of Internal Medicine 3, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Department of Internal Medicine 1, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Department of Internal Medicine 2, Division of Cardiology, Medical University of Vienna, Vienna, Austria. Electronic address: christian.nitsche@meduniwien.ac.at.

Förderung

  • Medizinische Universität Wien
  • Austrian Society of Cardiology

Zitieren

APA

Halavina, K., Koschutnik, M., Donà, C., Autherith, M., Petric, F., Röckel, A., Spinka, G., Danesh, D., Puchinger, J., Wiesholzer, M., Mascherbauer, K., Heitzinger, G., Dannenberg, V., Koschatko, S., Jantsch, C., Winter, M. P., Goliasch, G., Kammerlander, A. A., Bartko, P. E., …, & Nitsche, C. (2024). Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR). JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.06.022

Vancouver

Halavina K, Koschutnik M, Donà C, Autherith M, Petric F, Röckel A, et al. Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR). JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.06.022

BibTeX
@article{Halavina2024,
  author = {Halavina, Kseniya and Koschutnik, Matthias and Donà, Carolina and Autherith, Maximilian and Petric, Fabian and Röckel, Anna and Spinka, Georg and Danesh, Daryush and Puchinger, Jürgen and Wiesholzer, Martin and Mascherbauer, Katharina and Heitzinger, Gregor and Dannenberg, Varius and Koschatko, Sophia and Jantsch, Charlotte and Winter, Max-Paul and Goliasch, Georg and Kammerlander, Andreas A and Bartko, Philipp E and Hengstenberg, Christian and Mascherbauer, Julia and Nitsche, Christian},
  title = {Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR)},
  journal = {JACC: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1016/j.jcin.2024.06.022}
}
Kostenlos starten →